Results of cohort A according to neuropsychiatric diagnoses of the mother and offspring
| Mothers with subsequent psychosis and individually matched control mothers | |||
| N | CBA-positive (NMDAR/CASPR2) | CBA-negative | |
| Mother | |||
| Psychosis | 94 | 8 (7/1) | 86 |
| No psychosis | 93 | 6 (4/2) | 87 |
| Offspring | |||
| Developmental disorder | 28 | 5 (4/1) | 23 |
| MR/DPD | 11 | 5 (4/1) | 6 |
| Schizophrenia | 3 | 0 | 3 |
| Hyperkinetic disorders | 10 | 0 | 10 |
| Multiple diagnoses (not including MR/DPD) | 4 | 0 | 4 |
| No neurodevelopmental disorder | 159 | 9 (7/2) | 150 |
CASPR2, contactin-associated protein-like 2; MR/DPD, mental retardation and/or disorders of psychological development; NMDAR, N-methyl-D-aspartate receptor. CBA = cell-based assay.